Tango Therapeutics, Inc. (TNGX) Net Cash Provided by (Used in) Financing Activities USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Tango Therapeutics, Inc. quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from 2020 to 2024.
  • Tango Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $43M, a 58779% increase year-over-year.
Net Cash Provided by (Used in) Financing Activities, Trailing 12 Months (USD)
Net Cash Provided by (Used in) Financing Activities, Quarterly Data (USD)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $43M +$42.9M +58779% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $82.4M +$80.8M +5003% Dec 31, 2023 10-K 2024-03-18
Q1 2023 $73K* -$184K -71.6% Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $1.62M -$356M -99.5% Dec 31, 2022 10-K 2024-03-18
Q1 2022 $257K -$30.2M -99.2% Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $357M +$276M +342% Dec 31, 2021 10-K 2023-03-27
Q1 2021 $30.4M Mar 31, 2021 10-Q 2022-05-11
Q4 2020 $80.9M Dec 31, 2020 10-K 2022-03-28
Q3 2020 $168M Sep 30, 2020 10-Q 2020-11-13
Q2 2020 $25K* Jun 30, 2020 10-Q 2021-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.